Literature DB >> 3262845

Herpes zoster ophthalmicus complicated by hyphema and hemorrhagic glaucoma.

S Hayasaka1, M Watanabe, Y Yamamoto, S Noda, M Sekimoto, T Setogawa.   

Abstract

We treated two patients with herpes zoster ophthalmicus in whom hyphema and hemorrhagic glaucoma occurred. Case 1 complained of facial skin eruption, and was given intravenous acyclovir for 7 days. Hyphema and high intraocular pressure occurred in the left eye 10 days after the onset of the skin eruption. Case 2 had severe pain and blisters on her face, and was given intravenous acyclovir for 7 days. An intracameral hemorrhage and glaucoma developed in the right eye 15 days after the onset of the skin lesion. Intravenous acyclovir may be necessary for longer than 7-day periods if the iridocyclitis remains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262845     DOI: 10.1159/000309898

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  4 in total

1.  Cutaneous eruption with or without ocular complications in patients with herpes zoster involving the trigeminal nerve.

Authors:  K Yamada; S Hayasaka; Y Yamamoto; T Setogawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Genetic analysis of varicella-zoster virus in the aqueous humor in uveitis with severe hyphema.

Authors:  Mayumi Hosogai; Yoko Nakatani; Kensuke Mimura; Shoji Kishi; Hideo Akiyama
Journal:  BMC Infect Dis       Date:  2017-06-15       Impact factor: 3.090

3.  Ophthalmic herpes zoster with severe complications in an immunocompromised patient: A case report and review of the literature.

Authors:  Gabriela Mariana Iancu; Dan Mircea Stănilă; Remus Călin Cipăian; Maria Rotaru
Journal:  Exp Ther Med       Date:  2022-01-11       Impact factor: 2.447

4.  A case of herpes zoster uveitis with severe hyphema.

Authors:  Yoko Okunuki; Junichi Sakai; Takeshi Kezuka; Hiroshi Goto
Journal:  BMC Ophthalmol       Date:  2014-05-29       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.